2 options
The firm and the FDA : McKinsey & Company's conflicts of interest at the heart of the opioid epidemic : interim majority staff report / Committee on Oversight and Reform, U.S. House of Representatives.
- Format:
- Book
- Government document
- Author/Creator:
- United States. Congress. House. Committee on Oversight and Reform, author.
- Language:
- English
- Subjects (All):
- McKinsey and Company--Corrupt practices.
- McKinsey and Company.
- Conflict of interests--United States.
- Conflict of interests.
- Opioid abuse--United States.
- Opioid abuse.
- Drugs--Overdose--United States.
- Drugs.
- Drugs--United States--Marketing.
- Pharmaceutical industry--Corrupt practices--United States.
- Pharmaceutical industry.
- Corruption.
- Drugs--Marketing.
- Drugs--Overdose.
- Pharmaceutical industry--Corrupt practices.
- United States.
- Physical Description:
- 1 online resource (53 pages) : color illustrations
- Other Title:
- Firm and the Food and Drug Administration
- McKinsey & Company's conflicts of interest at the heart of the opioid epidemic
- Place of Publication:
- [Washington, D.C.] : Committee on Oversight and Reform, U.S. House of Representatives, 2022.
- Notes:
- "April 13, 2022."
- Includes bibliographical references.
- Description based on online resource; title from PDF title page (Oversight, viewed May 10, 2022).
- OCLC:
- 1319037359
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.